stroke rate
6.8
paraplegia
2.7
%
complete/partial thrombosis of the false lumen in dissection
stent region
88.9
At 30 days:
11,000+ devices implanted globally
Source: Summary of Clinical Data for IFU 441-01EN (Zenith Dissection Endovascular System).
73 patients were included in the Global Clinical Study.
%
complete/partial thrombosis of the false lumen in stent graft region
97.9
%
%
stroke rate
%
1.8
paraplegia
0
%
complete/partial thrombosis of the false lumen in dissection
stent region
.4
%
complete/partial thrombosis of the false lumen in stent graft region
100
%
At one year:
97
Designed to minimize graft- and
procedure-induced trauma and complications.
Minimize the risk
30 day data
1 year data
THORACIC DISSECTIONS
Zenith Flex® AAA
Endovascular Graft
Zenith® Fenestrated
AAA Endovascular Graft
Zenith Alpha® Thoracic Endovascular Graft
Zenith® Dissection Endovascular System
Land the graft exactly where you
want it with precise control.
At five years:
40,000+ devices implanted globally
99
%
freedom from TAA-related mortality
0
proximal
type I, III, or IV endoleaks
0
%
migration
> 10 mm*
*Based upon new presentation at 5 years. (3 patients had cranial migration of the distal end, first noted at 2 years).
Source: Zenith Alpha Thoracic 2017-2018 clinical update. 110 patients were included in the Global Clinical Study.
THORACIC ANEURYSMS AND ULCERS
ruptures
0
component separations
0
Durable by design
5 year data
Zenith Flex® AAA
Endovascular Graft
Zenith® Fenestrated
AAA Endovascular Graft
Zenith Alpha® Thoracic Endovascular Graft
Zenith® Dissection Endovascular System
Backed by 5-year data*
Rigorously tested for aneurysms with infrarenal
seal zones ≥ 4 mm to < 15 mm.
At five years:
10,000+ devices implanted globally
0
ruptures or conversions to open repair
97
%
survival from aneurysm related mortality
freedom
from major
morbidity
95.5
decrease (>5mm)
or no change (<5mm)
in aneurysm size
*Source: Zenith Fenestrated 2019 clinical update
Abdominal ANEURYSMS
.3
%
%
95.5
freedom
from limb-related reintervention
%
98
aortic
ruptures
0
limb
patency
98
.3
%
At one year:
40,000+ devices implanted globally
*Source: Lindsay et al., 2020
Designed to maintain patency and seal in a range of iliac anatomy.
Zenith® Spiral-Z®:
Enhanced graft flexibility
5 year data
Zenith Flex® AAA
Endovascular Graft
Zenith® Fenestrated
AAA Endovascular Graft
Zenith Alpha® Thoracic Endovascular Graft
Zenith® Dissection Endovascular System
Backed by long-term data*
Proven endoleak and migration resistance
by pivotal study data
At five years:
10,000+ devices implanted globally
0
type I proximal,
type III or IV endoleaks
72
%
sac
shrinkage
exhibited no
aneurysm
growth
91
migration
> 10mm
Source: Zenith Flex 2012 clinical update
Abdominal ANEURYSMS
%
%
0
freedom from aneurysm sac
growth
%
74.1
freedom from
late reintervention and conversion
%
69.9
freedom from AAA-rupture
98.1
%
At 14 years:
Source: Verzini et al., 2017
100,000+ devices implanted globally
*
*
*
*These are approximate values based on Verzini et al.
5 year data
freedom
from limb-related reintervention
%
98
aortic
ruptures
0
limb
patency
98
.3
%
At one year:
40,000+ devices implanted globally
*Source: Lindsay et al., 2020
Designed to maintain patency and seal in a range of iliac anatomy.
Zenith® Spiral-Z®:
Enhanced graft flexibility
14 year data
Zenith Flex® AAA
Endovascular Graft
Zenith® Fenestrated
AAA Endovascular Graft
Zenith Alpha® Thoracic Endovascular Graft
Zenith® Dissection Endovascular System
